Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.508 SEK | -66.28% |
|
+98.14% | +303.28% |
06-26 | Alligator Bioscience Announces Results from the Ongoing Optimize-1 Trial | CI |
06-20 | Alligator Bioscience AB to Present Positive Phase 2 Data on Mitazalimab in Pancreatic Cancer at ESMO GI 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALLIGATOR BIOSCIENCE AB | Other Biotechnology & Medical Research | -66.28% | +98.14% | +303.28% | +430.32% | -90.20% | 85.82M | - | - | - |
- Stock Market
- Equities
- ATORX Stock
- 0RK9 Stock
- Charts Alligator Bioscience AB
- Relative Strength Chart